Drug Profile
RD 62198
Alternative Names: RD6-2198Latest Information Update: 22 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections; HIV infections
Most Recent Events
- 22 Jun 2001 No-Development-Reported for Herpes simplex virus infections in Japan (Unknown route)
- 22 Jun 2001 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 30 Sep 1998 A preclinical study has been added to the Viral Infections antimicrobial activity and pharmacodynamics sections